Kenichiro Morisawa
St. Marianna University School of Medicine
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Kenichiro Morisawa.
Clinical Infectious Diseases | 2013
Yoshiro Hayashi; Kenichiro Morisawa; Michael Klompas; Mark Jones; Hiran Bandeshe; Robert J. Boots; Jeffrey Lipman; David L. Paterson
BACKGROUND Hospitals and quality improvement agencies are vigorously focusing on reducing rates of hospital-acquired infection. Ventilator-associated pneumonia (VAP) is notoriously difficult to diagnose and surveillance is thwarted by the subjectivity of many components of the surveillance definition. Alternative surveillance strategies are needed. Ventilator-associated complications (VAC) is a simple, objective measure of respiratory deterioration. METHODS VAC is defined by increases in fraction of inspired oxygen (FiO(2)) by ≥ 15% or positive end-expiratory pressure (PEEP) by ≥ 2.5 cm H(2)O lasting ≥ 2 days after stable or decreasing FiO(2) or PEEP lasting ≥ 2 days. We retrospectively assessed patients on mechanical ventilation for ≥ 48 hours in our study intensive care unit (ICU) using electronic medical record data. We analyzed the association between VAC and clinical diagnoses, ICU length of stay, duration of mechanical ventilation, antibiotic use, and mortality. RESULTS We assessed 153 patients with VAC and 390 without VAC. VAC events were associated with significantly increased ICU length of stay, duration of mechanical ventilation, and consumption of broad-spectrum antibiotics but not with longer hospital stays or ICU mortality. CONCLUSIONS Surveillance for VAP is subjective and labor intensive. VAC is an objective measure which can be readily obtained from electronic records. It is associated with adverse outcomes and increased broad-spectrum antibiotic usage. VAC may be a useful surveillance tool. The utility of VAC prevention bundles merits assessment.
American Journal of Infection Control | 2012
Haruaki Wakatake; Shigeki Fujitani; Takamitsu Kodama; Eiji Kawamoto; Hiroyuki Yamada; Machi Yanai; Kenichiro Morisawa; Hiromu Takemura; Alan T. Lefor; Yasuhiko Taira
BACKGROUND This study was undertaken to determine the rate of methicillin-resistant Staphylococcus aureus (MRSA) colonization predicted by clinical risk factors compared with determination by nasal swab culture and polymerase chain reaction in emergency department patients. METHODS From November 2009 to March 2011, patients seen in the emergency department were studied prospectively. The risk of MRSA colonization was determined by clinical risk factors, and both surveillance cultures and a polymerase chain reaction assay were performed in each patient. RESULTS A total of 277 patients was enrolled, and 31.4% (87/277) of patients had a positive surveillance culture or a MRSA polymerase chain reaction assay. The rate of colonization in patients with high-risk factors included the following: past history of colonization/infections, 60.0%; history of previous antibiotic use, 47.2%; more than 30 days hospitalization in the past 3 months, 43.9%; more than 10 days hospitalization in the past 3 months, 41.7%; and a history of hospitalization because of acute illness, 40.0%. CONCLUSION The prevalence rate of colonization in patients with a high risk of MRSA colonization exceeded 30%. Active surveillance cultures should be considered in patients at high risk for MRSA colonization.
Journal of intensive care | 2014
Kenichiro Morisawa; Shigeki Fujitani; Yasuhiko Taira; Shigeki Kushimoto; Yasuhide Kitazawa; Kazuo Okuchi; Hiroyasu Ishikura; Teruo Sakamoto; Takashi Tagami; Junko Yamaguchi; Manabu Sugita; Yoichi Kase; Takashi Kanemura; Hiroyuki Takahashi; Yuuichi Kuroki; Hiroo Izumino; Hiroshi Rinka; Ryutarou Seo; Makoto Takatori; Tadashi Kaneko; Toshiaki Nakamura; Takayuki Irahara; Nobuyuki Saitou; Akihiro Watanabe
BackgroundAcute respiratory distress syndrome (ARDS) is characterized by the increased pulmonary permeability secondary to diffuse alveolar inflammation and injuries of several origins. Especially, the distinction between a direct (pulmonary injury) and an indirect (extrapulmonary injury) lung injury etiology is gaining more attention as a means of better comprehending the pathophysiology of ARDS. However, there are few reports regarding the quantitative methods distinguishing the degree of pulmonary permeability between ARDS patients due to pulmonary injury and extrapulmonary injury.MethodsA prospective, observational, multi-institutional study was performed in 23 intensive care units of academic tertiary referral hospitals throughout Japan. During a 2-year period, all consecutive ARDS-diagnosed adult patients requiring mechanical ventilation were collected in which three experts retrospectively determined the pathophysiological mechanisms leading to ARDS. Patients were classified into two groups: patients with ARDS triggered by extrapulmonary injury (ARDSexp) and those caused by pulmonary injury (ARDSp). The degree of pulmonary permeability using the transpulmonary thermodilution technique was obtained during the first three intensive care unit (ICU) days.ResultsIn total, 173 patients were assessed including 56 ARDSexp patients and 117 ARDSp patients. Although the Sequential Organ Failure Assessment (SOFA) score was significantly higher in the ARDSexp group than in the ARDSp group, measurements of the pulmonary vascular permeability index (PVPI) were significantly elevated in the ARDSp group on all days: at day 0 (2.9 ± 1.3 of ARDSexp vs. 3.3 ± 1.3 of ARDSp, p = .008), at day 1 (2.8 ± 1.5 of ARDSexp vs. 3.2 ± 1.2 of ARDSp, p = .01), at day 2 (2.4 ± 1.0 of ARDSexp vs. 2.9 ± 1.3 of ARDSp, p = .01). There were no significant differences in mortality at 28 days, mechanical ventilation days, and hospital length of stay between the two groups.ConclusionsThe results of this study suggest the existence of several differences in the increased degree of pulmonary permeability between patients with ARDSexp and ARDSp.Trial registrationThis report is a sub-group analysis of the study registered with UMIN-CTR (IDUMIN000003627).
Annals of Intensive Care | 2014
Takashi Tagami; Toshiaki Nakamura; Shigeki Kushimoto; Ryoichi Tosa; Akihiro Watanabe; Tadashi Kaneko; Hidetada Fukushima; Hiroshi Rinka; Daisuke Kudo; Hideaki Uzu; Akira Murai; Makoto Takatori; Hiroo Izumino; Yoichi Kase; Ryutarou Seo; Hiroyuki Takahashi; Yasuhide Kitazawa; Junko Yamaguchi; Manabu Sugita; Yuichi Kuroki; Takashi Kanemura; Kenichiro Morisawa; Nobuyuki Saito; Takayuki Irahara; Hiroyuki Yokota
Critical Care | 2006
Kenichiro Morisawa; Yasuhiko Taira; H Takahashi; K Matsui; M Ouchi; N Fujinawa; K Noda
Critical Care | 2008
Kenichiro Morisawa; Shigeki Fujitani; H Takahashi; H Oohashi; S Ishigouoka; Machi Yanai; Y Masui; Yasuhiko Taira
Critical Care | 2007
Kenichiro Morisawa; Yasuhiko Taira
Critical Care Medicine | 2018
Kazuaki Shigemitsu; Hiroshi Rinka; Kenichiro Morisawa; Shigeki Fujitani; Yasuhiko Taira
Critical Care Medicine | 2016
Jumpei Tsukuda; Miyuki Kurisu; Takeshi Kawaguchi; Yuka Takamatsu; Machi Yanai; Kenichiro Morisawa; Shigeki Fujitani; Yasuhiko Taira
Critical Care Medicine | 2013
Tetsuo Kobayashi; Kenichiro Morisawa; Machi Yanai; Yuka Takamatsu; Lohman; Yasuhiko Taira; Moroe Beppu